Cited by 490Autophagy in Disease and TherapyCardiovascular Function and Risk FactorsMetabolism, Diabetes, and Cancer

Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice

Open access
Xie, Zhonglin, Lau, Kai, Eby, Bonnie, Lozano, Pedro, He, Chaoyong, Pennington, Becky, Li, Hongliang, Rathi, Shradha +4 more·2011·Diabetes

Abstract

OBJECTIVE: Autophagy is a critical cellular system for removal of aggregated proteins and damaged organelles. Although dysregulated autophagy is implicated in the development of heart failure, the role of autophagy in the development of diabetic cardiomyopathy has not been studied. We investigated whether chronic activation of the AMP-activated protein kinase (AMPK) by metformin restores cardiac function and cardiomyocyte autophagy in OVE26 diabetic mice. RESEARCH DESIGN AND METHODS: OVE26 mice and cardiac-specific AMPK dominant negative transgenic (DN)-AMPK diabetic mice were treated with metformin or vehicle for 4 months, and cardiac autophagy, cardiac functions, and cardiomyocyte apoptosis were monitored. RESULTS: Compared with control mice, diabetic OVE26 mice exhibited a significant reduction of AMPK activity in parallel with reduced cardiomyocyte autophagy and cardiac dysfunction in vivo and in isolated hearts. Furthermore, diabetic OVE26 mouse hearts exhibited aggregation of chaotically distributed mitochondria between poorly organized myofibrils and increased polyubiquitinated protein and apoptosis. Inhibition of AMPK by overexpression of a cardiac-specific DN-AMPK gene reduced cardiomyocyte autophagy, exacerbated cardiac dysfunctions, and increased mortality in diabetic mice. Finally, chronic metformin therapy significantly enhanced autophagic activity and preserved cardiac functions in diabetic OVE26 mice but not in DN-AMPK diabetic mice. CONCLUSIONS: Decreased AMPK activity and subsequent reduction in cardiac autophagy are important events in the development of diabetic cardiomyopathy. Chronic AMPK activation by metformin prevents cardiomyopathy by upregulating autophagy activity in diabetic OVE26 mice. Thus, stimulation of AMPK may represent a novel approach to treat diabetic cardiomyopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db10-0351

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In OVE26 diabetic mice, isolated hearts showed a substantial reduction in AMPK function and cardiomyocyte autophagy as well as mitochondria aggregations and increased apoptosis that was reversed following chronic treatment with metformin.

    “Isolated hearts, from the diabetic mice showed a substantial reduction in AMPK function and cardiomyocyte autophagy as well as mitochondria aggregations dispersed between poorly organized myofibrils and increased apoptosis that was reversed following chronic treatment with metformin (231).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., Kem, D., & Zou, M.-H.
Affiliations
  • University of Oklahoma Health Sciences Center (US)
  • Oklahoma City VA Medical Center (US)
  • University of Washington (US)
Corresponding author
Xie, Zhonglin
Venue
Diabetes
Published
2011-05-21
Volume
60
Issue
6
Pages
1770-1778
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2096317893
Cited by
490
References
49
Citations by year
2026: 9 · 2025: 23 · 2024: 22 · 2023: 30 · 2022: 30 · 2021: 38 · 2020: 59 · 2019: 35 · 2018: 34 · 2017: 44 · 2016: 35 · 2015: 36 · 2014: 42 · 2013: 21 · 2012: 23
FWCI
22.66
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • American Heart Association
  • Fraternal Order of Eagles
  • University of Oklahoma
  • Oklahoma Center for the Advancement of Science and Technology
  • National Institutes of Health
  • University of Oklahoma Health Sciences Center
  • National Heart, Lung, and Blood Institute (R01HL105157, HL 079584, R01HL079584, HL-080499, HL096032, HL074399, R01HL074399, R01HL080499, HL-089920, R01HL110488, R01HL089920, R01HL096032)
  • National Center for Research Resources (P20RR024215)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
metformin, cardiac autophagy, diabetic cardiomyopathy, AMPK, cardiomyocyte apoptosis, mitochondrial aggregation, polyubiquitinated proteins, cardiac dysfunction, heart failure
MeSH terms
Beclin-1, Animals, Autophagy, Echocardiography, Hypoglycemic Agents, Immunohistochemistry, Male, Metformin, Cardiomyopathies, Myocardium, Tuberous Sclerosis, Blotting, Western, Apoptosis, In Situ Nick-End Labeling, Myocytes, Cardiac, Microscopy, Electron, Transmission, Apoptosis Regulatory Proteins, Mice, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review